605116.SS logo

605116.SS Aurisco Pharmaceutical Co.,Ltd.

Shanghai Stock Exchange · Medical - Pharmaceuticals · Healthcare

$20.83
-0.34 (-1.61%)

Aurisco Pharmaceutical Co.,Ltd. engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides dexamethasone is used to treat skin diseases; fluticasone p…

Market Cap: $8.46Bwww.aurisco.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 12Aug 12

Quote

Day Range
52-Week Range
Volume
Market Cap
50-Day Avg
200-Day Avg
Prev Close
Open

Valuation & Ratios

P/E Ratio
EPS
P/B Ratio
P/S Ratio
Debt/Equity
Current Ratio
Dividend Yield
Gross Margin

Returns & Efficiency

Return on Equity
Return on Assets
FCF Yield
EV/EBITDA

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Valuation

605116.SShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsprnewswire.com·3d ago·Neutral

    Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA /PRNewswire/ -- Aurisco Pharmaceutical, a leading global Oligonucleotide and Peptide (TIDES) manufacturer, announced today that its site in Yangzhou, China has

    View source ↗